PT Bundamedik Tbk (IDX:BMHS)
189.00
-2.00 (-1.05%)
Aug 12, 2026, 4:00 PM WIB
PT Bundamedik Tbk Revenue
PT Bundamedik Tbk had revenue of 396.45B IDR in the quarter ending June 30, 2026, with 4.67% growth. This brings the company's revenue in the last twelve months to 1.62T, up 6.29% year-over-year. In the year 2025, PT Bundamedik Tbk had annual revenue of 1.61T with 3.84% growth.
Revenue (ttm)
1.62T
Revenue Growth
+6.29%
P/S Ratio
1.00
Revenue / Employee
907.82M
Employees
1,789
Market Cap
1.63T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.61T | 59.66B | 3.84% |
| Dec 31, 2024 | 1.55T | 66.49B | 4.47% |
| Dec 31, 2023 | 1.49T | -170.49B | -10.28% |
| Dec 31, 2022 | 1.66T | -232.11B | -12.28% |
| Dec 31, 2021 | 1.89T | 742.66B | 64.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PT Lippo Karawaci Tbk | 8.35T |
| PT Medikaloka Hermina Tbk | 7.35T |
| PT Famon Awal Bros Sedaya Tbk | 2.77T |
| PT Sarana Meditama Metropolitan Tbk | 1.98T |
| PT Murni Sadar Tbk | 1.51T |
| PT Nitrasanata Dharma | 926.76B |
| PT Kedoya Adyaraya Tbk | 511.62B |
| PT Metro Healthcare Indonesia Tbk | 493.13B |